Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Machiela, Mitchell JHofmann, Jonathan N
Carreras-Torres, Robert
Brown, Kevin M
Johansson, Mattias
Wang, Zhaoming
Foll, Matthieu
Li, Peng
Rothman, Nathaniel
Savage, Sharon A
Gaborieau, Valerie
McKay, James D
Ye, Yuanqing
Henrion, Marc
Bruinsma, Fiona
Jordan, Susan
Severi, Gianluca
Hveem, Kristian
Vatten, Lars J
Fletcher, Tony
Koppova, Kvetoslava
Larsson, Susanna C
Wolk, Alicja
Banks, Rosamonde E
Selby, Peter J
Easton, Douglas F
Pharoah, Paul
Andreotti, Gabriella
Freeman, Laura E Beane
Koutros, Stella
Albanes, Demetrius
Mannisto, Satu
Weinstein, Stephanie
Clark, Peter E
Edwards, Todd E
Lipworth, Loren
Gapstur, Susan M
Stevens, Victoria L
Carol, Hallie
Freedman, Matthew L
Pomerantz, Mark M
Cho, Eunyoung
Kraft, Peter
Preston, Mark A
Wilson, Kathryn M
Gaziano, J Michael
Sesso, Howard S
Black, Amanda
Freedman, Neal D
Huang, Wen-Yi
Anema, John G
Kahnoski, Richard J
Lane, Brian R
Noyes, Sabrina L
Petillo, David
Colli, Leandro M
Sampson, Joshua N
Besse, Celine
Blanche, Helene
Boland, Anne
Burdette, Laurie
Prokhortchouk, Egor
Skryabin, Konstantin G
Yeager, Meredith
Mijuskovic, Mirjana
Ognjanovic, Miodrag
Foretova, Lenka
Holcatova, Ivana
Janout, Vladimir
Mates, Dana
Mukeriya, Anush
Rascu, Stefan
Zaridze, David
Bencko, Vladimir
Cybulski, Cezary
Fabianova, Eleonora
Jinga, Viorel
Lissowska, Jolanta
Lubinski, Jan
Navratilova, Marie
Rudnai, Peter
Szeszenia-Dabrowska, Neonila
Benhamou, Simone
Cancel-Tassin, Geraldine
Cussenot, Olivier
Bueno-de-Mesquita, H Bas
Canzian, Federico
Duell, Eric J
Ljungberg, Börje
Sitaram, Raviprakash T
Peters, Ulrike
White, Emily
Anderson, Garnet L
Johnson, Lisa
Luo, Juhua
Buring, Julie
Lee, I-Min
Chow, Wong-Ho
Moore, Lee E
Wood, Christopher
Eisen, Timothy
Larkin, James
Choueiri, Toni K
Lathrop, G Mark
Teh, Bin Tean
Deleuze, Jean-Francois
Wu, Xifeng
Houlston, Richard S
Brennan, Paul
Chanock, Stephen J
Scelo, Ghislaine
Purdue, Mark P
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.Published in
Eur Urol 2017, 72(5):747-54Publiekssamenvatting
Relative telomere length in peripheral blood leukocytes has been evaluated as a potential biomarker for renal cell carcinoma (RCC) risk in several studies, with conflicting findings.PMID
28797570ae974a485f413a2113503eed53cd6c53
10.1016/j.eururo.2017.07.015
Scopus Count
Collections
Related articles
- High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
- Authors: Chen M, Tsai CW, Chang WS, Xiong GY, Xu Y, Bau DT, Gu J
- Issue date: 2021 Jun 21
- Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
- Authors: Telomeres Mendelian Randomization Collaboration, Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, Willeit P, Aviv A, Gaunt TR, Hemani G, Mangino M, Ellis HP, Kurian KM, Pooley KA, Eeles RA, Lee JE, Fang S, Chen WV, Law MH, Bowdler LM, Iles MM, Yang Q, Worrall BB, Markus HS, Hung RJ, Amos CI, Spurdle AB, Thompson DJ, O'Mara TA, Wolpin B, Amundadottir L, Stolzenberg-Solomon R, Trichopoulou A, Onland-Moret NC, Lund E, Duell EJ, Canzian F, Severi G, Overvad K, Gunter MJ, Tumino R, Svenson U, van Rij A, Baas AF, Bown MJ, Samani NJ, van t'Hof FNG, Tromp G, Jones GT, Kuivaniemi H, Elmore JR, Johansson M, Mckay J, Scelo G, Carreras-Torres R, Gaborieau V, Brennan P, Bracci PM, Neale RE, Olson SH, Gallinger S, Li D, Petersen GM, Risch HA, Klein AP, Han J, Abnet CC, Freedman ND, Taylor PR, Maris JM, Aben KK, Kiemeney LA, Vermeulen SH, Wiencke JK, Walsh KM, Wrensch M, Rice T, Turnbull C, Litchfield K, Paternoster L, Standl M, Abecasis GR, SanGiovanni JP, Li Y, Mijatovic V, Sapkota Y, Low SK, Zondervan KT, Montgomery GW, Nyholt DR, van Heel DA, Hunt K, Arking DE, Ashar FN, Sotoodehnia N, Woo D, Rosand J, Comeau ME, Brown WM, Silverman EK, Hokanson JE, Cho MH, Hui J, Ferreira MA, Thompson PJ, Morrison AC, Felix JF, Smith NL, Christiano AM, Petukhova L, Betz RC, Fan X, Zhang X, Zhu C, Langefeld CD, Thompson SD, Wang F, Lin X, Schwartz DA, Fingerlin T, Rotter JI, Cotch MF, Jensen RA, Munz M, Dommisch H, Schaefer AS, Han F, Ollila HM, Hillary RP, Albagha O, Ralston SH, Zeng C, Zheng W, Shu XO, Reis A, Uebe S, Hüffmeier U, Kawamura Y, Otowa T, Sasaki T, Hibberd ML, Davila S, Xie G, Siminovitch K, Bei JX, Zeng YX, Försti A, Chen B, Landi S, Franke A, Fischer A, Ellinghaus D, Flores C, Noth I, Ma SF, Foo JN, Liu J, Kim JW, Cox DG, Delattre O, Mirabeau O, Skibola CF, Tang CS, Garcia-Barcelo M, Chang KP, Su WH, Chang YS, Martin NG, Gordon S, Wade TD, Lee C, Kubo M, Cha PC, Nakamura Y, Levy D, Kimura M, Hwang SJ, Hunt S, Spector T, Soranzo N, Manichaikul AW, Barr RG, Kahali B, Speliotes E, Yerges-Armstrong LM, Cheng CY, Jonas JB, Wong TY, Fogh I, Lin K, Powell JF, Rice K, Relton CL, Martin RM, Davey Smith G
- Issue date: 2017 May 1
- A prospective study of leukocyte telomere length and risk of renal cell carcinoma.
- Authors: Hofmann JN, Lan Q, Cawthon R, Hosgood HD 3rd, Shuch B, Moore LE, Rothman N, Chow WH, Purdue MP
- Issue date: 2013 May
- Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
- Authors: de Martino M, Taus C, Lucca I, Hofbauer SL, Haitel A, Shariat SF, Klatte T
- Issue date: 2016 Oct
- Mendelian randomization study of telomere length and lung cancer risk in East Asian population.
- Authors: Cao X, Huang M, Zhu M, Fang R, Ma Z, Jiang T, Dai J, Ma H, Jin G, Shen H, Du J, Xu L, Hu Z
- Issue date: 2019 Dec
Related items
Showing items related by title, author, creator and subject.
-
Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54].Machiela, Mitchell J; Hofmann, Jonathan N; Carreras-Torres, Robert; Brown, Kevin M; Johansson, Mattias; Wang, Zhaoming; Foll, Matthieu; Li, Peng; Rothman, Nathaniel; Savage, Sharon A; et al. (2018-05-28)
-
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses.Seyed Khoei, Nazlisadat; Jenab, Mazda; Murphy, Neil; Banbury, Barbara L; Carreras-Torres, Robert; Viallon, Vivian; Kühn, Tilman; Bueno-de-Mesquita, Bas; Aleksandrova, Krasimira; Cross, Amanda J; et al. (2020-09-03)In a case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC), pre-diagnostic unconjugated bilirubin (UCB, the main component of total bilirubin) concentrations were measured by high-performance liquid chromatography in plasma samples of 1386 CRC cases and their individually matched controls. Additionally, 115 single-nucleotide polymorphisms (SNPs) robustly associated (P < 5 × 10-8) with circulating total bilirubin were instrumented in a 2-sample MR to test for a potential causal effect of bilirubin on CRC risk in 52,775 CRC cases and 45,940 matched controls in the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), the Colon Cancer Family Registry (CCFR), and the Colorectal Transdisciplinary (CORECT) study.
-
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.Klein, Alison P; Wolpin, Brian M; Risch, Harvey A; Stolzenberg-Solomon, Rachael Z; Mocci, Evelina; Zhang, Mingfeng; Canzian, Federico; Childs, Erica J; Hoskins, Jason W; Jermusyk, Ashley; et al. (2018-02-08)In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer GWAS to date, including 9040 patients and 12,496 controls of European ancestry from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). Here, we find significant evidence of a novel association at rs78417682 (7p12/TNS3, P = 4.35 × 10-8). Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10-14), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10-10), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10-8), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10-8). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA. Expression quantitative trait locus analysis in three independent pancreatic data sets provides molecular support of NOC2L as a pancreatic cancer susceptibility gene.